New Weight-Loss Drug Shows Promise
(HealthDay)


HealthDay - FRIDAY, Sept. 29 (HealthDay News) -- Patients taking an investigational weight-loss drug called Contrave lost an average of more than 7 percent of their weight in the first 24 weeks of a phase III clinical trial, according to interim findings released this week by the company that developed the drug.